A structure-based approach to evaluation product adaptability in adaptable design

被引:21
|
作者
Cheng, Qiang [2 ]
Zhang, Guojun [1 ]
Liu, Zhifeng [2 ]
Gu, Peihua [3 ]
Cai, Ligang [2 ]
机构
[1] Huazhong Univ Sci & Technol, State Engn Res Ctr Mfg Equipment Digitalizat, Wuhan 430074, Hubei, Peoples R China
[2] Beijing Univ Technol, Coll Mech Engn & Appl Elect Technol, Beijing 100124, Peoples R China
[3] Shantou Univ, Dept Mechatron Engn, Shantou 515063, Guangdong, Peoples R China
基金
中国国家自然科学基金; 国家高技术研究发展计划(863计划);
关键词
Adaptable design; Adaptability; Modular design; Interface; Kano's model; MODULE IDENTIFICATION; COMPLEXITY; MODEL;
D O I
10.1007/s12206-011-0224-3
中图分类号
TH [机械、仪表工业];
学科分类号
0802 ;
摘要
Adaptable design, as a new design paradigm, involves creating designs and products that can be easily changed to satisfy different requirements. In this paper, two types of product adaptability are proposed as essential adaptability and behavioral adaptability, and through measuring which respectively a model for product adaptability evaluation is developed. The essential adaptability evaluation proceeds with analyzing the independencies of function requirements and function modules firstly based on axiomatic design, and measuring the adaptability of interfaces secondly with three indices. The behavioral adaptability reflected by the performance of adaptable requirements after adaptation is measured based on Kano model. At last, the effectiveness of the proposed method is demonstrated by an illustrative example of the motherboard of a personal computer. The results show that the method can evaluate and reveal the adaptability of a product in essence, and is of directive significance to improving design and innovative design.
引用
收藏
页码:1081 / 1094
页数:14
相关论文
共 50 条
  • [41] NMR in structure-based drug design
    Carneiro, Marta G.
    Eiso, A. B.
    Theisgen, Stephan
    Siegal, Gregg
    STRUCTURE-BASED DRUG DESIGN: INSIGHTS FROM ACADEMIA AND INDUSTRY, 2017, 61 (05): : 485 - 493
  • [42] Structure-based design of opioid ligands
    Ferguson, David M.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2006, 231
  • [43] Advances in structure-based vaccine design
    Kulp, Daniel W.
    Schief, William R.
    CURRENT OPINION IN VIROLOGY, 2013, 3 (03) : 322 - 331
  • [44] Structure-based design of IAP antagonists
    Fairbrother, Wayne J.
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3623S - 3623S
  • [45] NMR STRUCTURE-BASED DRUG DESIGN
    FESIK, SW
    JOURNAL OF BIOMOLECULAR NMR, 1993, 3 (03) : 261 - 269
  • [46] Structure-Based Design of Ricin Inhibitors
    Jasheway, Karl
    Pruet, Jeffrey
    Anslyn, Eric V.
    Robertus, Jon D.
    TOXINS, 2011, 3 (10): : 1233 - 1248
  • [47] Structure-based design of model proteins
    Banavar, JR
    Cieplak, M
    Maritan, A
    Nadig, G
    Seno, F
    Vishveshwara, S
    PROTEINS-STRUCTURE FUNCTION AND GENETICS, 1998, 31 (01): : 10 - 20
  • [48] Structure-Based Design of a Macrocyclic PROTAC
    Testa, Andrea
    Hughes, Scott J.
    Lucas, Xavier
    Wright, Jane E.
    Ciulli, Alessio
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2020, 59 (04) : 1727 - 1734
  • [49] Progression in structure-based drug design
    Fong, F
    GENETIC ENGINEERING NEWS, 2004, 24 (07): : 26 - +
  • [50] Structure-based design of thrombin inhibitors
    Pfau, R
    CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT, 2003, 6 (04) : 437 - 450